ABNORMAL ERYTHROCYTE CHOLINE TRANSPORT IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引:14
|
作者
FERVENZA, FC
MEREDITH, D
ELLORY, JC
HENDRY, BM
机构
[1] JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND
[2] CHURCHILL HOSP, RENAL UNIT, OXFORD OX3 7LJ, ENGLAND
[3] UNIV OXFORD, PHYSIOL LAB, OXFORD, ENGLAND
关键词
CHOLINE; DIALYSIS; ERYTHROCYTE; MEMBRANE TRANSPORT; UREMIA;
D O I
10.1042/cs0800137
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Erythrocyte choline transport has been studied in nine patients on maintenance haemodialysis for chronic renal failure, six patients on continuous ambulatory peritoneal dialysis, 31 patients with renal transplants and in nine normal control subjects. 2. The mean maximum rate of choline influx (V(max.), measured at an extracellular choline concentration of 250-mu-mol/1) was 66.7 (SD 14.1) mu-mol h-1 l-1 cells in patients on haemodialysis, 87.8 (SD 18.5) mu-mol h-1 l-1 cells in patients on continuous ambulatory peritoneal dialysis and 30.5 (SD 4.9) mu-mol h-1 l-1 cells in control subjects. The increase in choline flux in patients on haemodialysis and patients on continuous ambulatory peritoneal dialysis compared with control subjects was highly significant (P < 0.001). 3. Renal transplant patients showed variable values for the V(max.) of choline influx (range 17.7-71.7-mu-mol h-1 l-1 cells). The values showed a significant negative correlation with creatinine clearance and this correlation correctly extrapolated to the maximum choline flux in normal subjects and in patients on dialysis. 4. The kinetics of choline transport have been studied in erythrocytes of patients on haemodialysis and control subjects in 'zero-trans' conditions after depletion of intracellular choline. The mean V(max.) in these conditions was 38.4 (SD 4.6) mu-mol h-1 l-1 cells in patients on haemodialysis compared with 14.2 (SD 3.7) mu-mol h-1 l-1 cells in control subjects. The mean K(m) under 'zero-trans' conditions was 19.4 (SD 2.4) mu-mol/l in patients on haemodialysis and 7.4 (SD 1.4) mu-mol/l in control subjects. These differences were significant (P < 0.001).
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [21] TUBERCULOSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    DEPAULA, FJ
    DEAZEVEDO, LSF
    IANHEZ, LE
    ROMAO, JE
    CHOCAIR, PR
    SABBAGA, E
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 1987, 29 (03): : 127 - 130
  • [22] ANEMIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    FRIED, W
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1980, 3 (02): : 62 - 64
  • [23] REHABILITATION OF PATIENTS WITH CHRONIC-RENAL-FAILURE
    KIELSTEIN, R
    LACHHEIN, L
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1981, 36 (36): : 1488 - 1491
  • [24] THROMBOELASTOGRAPHY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    PIVALIZZA, EG
    ABRAMSON, DC
    HARVEY, A
    KING, F
    ANESTHESIOLOGY, 1995, 83 (3A) : A90 - A90
  • [25] ENDOTHELIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    SAITO, Y
    KAZUWA, N
    SHIRAKAMI, G
    MUKOYAMA, M
    ARAI, H
    HOSODA, K
    SUGA, SI
    OGAWA, Y
    IMURA, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S437 - S439
  • [26] A CIRCULATING NA+-K+ATPASE INHIBITOR, ERYTHROCYTE SODIUM-TRANSPORT AND HYPERTENSION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    KARIYA, K
    SANO, H
    YAMANISHI, J
    SAITO, K
    FURUTA, Y
    FUKUZAKI, H
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1986, 8 (02) : 167 - 183
  • [27] ERYTHROCYTE TRANSPORT OF MAGNESIUM IN CHRONIC RENAL FAILURE
    SNYDER, D
    GORFIEN, P
    KRAMER, B
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A664 - +
  • [28] ACUTE-RENAL-FAILURE IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    OHNO, AK
    BARR, JG
    ABRAMS, JR
    GOUGE, SF
    CLINICAL RESEARCH, 1990, 38 (02): : A576 - A576
  • [29] RENAL VESICLE GLUTAMINE TRANSPORT IN HEALTH AND CHRONIC-RENAL-FAILURE
    WINDUS, D
    COHN, DE
    KLAHR, S
    HAMMERMAN, MR
    CLINICAL RESEARCH, 1982, 30 (04): : A788 - A788
  • [30] RENAL VESICLE GLUTAMINE TRANSPORT IN HEALTH AND CHRONIC-RENAL-FAILURE
    WINDUS, D
    KLAHR, S
    HAMMERMAN, MR
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 219 - 219